DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,254,850 | +12.7% | 25,211 | +9.0% | 0.36% | +18.7% |
| Q2 2023 | $5,550,000 | +10.7% | 23,125 | +16.2% | 0.30% | +2.0% |
| Q1 2023 | $5,014,337 | -5.0% | 19,895 | +0.1% | 0.29% | -13.6% |
| Q4 2022 | $5,276,285 | -14.3% | 19,879 | -16.6% | 0.34% | -21.9% |
| Q3 2022 | $6,158,000 | +6.7% | 23,840 | +4.7% | 0.43% | +10.2% |
| Q2 2022 | $5,772,000 | -10.9% | 22,769 | +3.1% | 0.39% | +6.2% |
| Q1 2022 | $6,478,000 | -8.9% | 22,085 | +2.2% | 0.37% | -7.0% |
| Q4 2021 | $7,111,000 | +10.4% | 21,612 | +2.1% | 0.40% | +0.3% |
| Q3 2021 | $6,442,000 | +14.2% | 21,162 | +0.7% | 0.40% | +15.7% |
| Q2 2021 | $5,640,000 | +48.3% | 21,014 | +24.3% | 0.34% | +18.6% |
| Q1 2021 | $3,804,000 | -4.4% | 16,900 | -5.7% | 0.29% | +7.4% |
| Q4 2020 | $3,981,000 | +4.7% | 17,923 | +1.5% | 0.27% | -20.1% |
| Q3 2020 | $3,801,000 | +20.7% | 17,652 | -0.8% | 0.34% | +13.4% |
| Q2 2020 | $3,148,000 | +26.7% | 17,801 | -0.8% | 0.30% | +6.8% |
| Q1 2020 | $2,484,000 | -15.2% | 17,944 | -6.0% | 0.28% | -3.5% |
| Q4 2019 | $2,930,000 | +4.9% | 19,088 | -1.3% | 0.29% | -1.0% |
| Q3 2019 | $2,793,000 | +1.6% | 19,336 | +0.5% | 0.29% | -3.0% |
| Q2 2019 | $2,748,000 | +10.8% | 19,234 | +2.4% | 0.30% | -2.6% |
| Q1 2019 | $2,481,000 | +35.6% | 18,791 | +5.9% | 0.31% | +19.3% |
| Q4 2018 | $1,830,000 | -4.3% | 17,748 | +0.9% | 0.26% | +9.7% |
| Q3 2018 | $1,912,000 | +9.3% | 17,594 | -0.7% | 0.24% | -0.4% |
| Q2 2018 | $1,749,000 | +2.0% | 17,726 | +1.3% | 0.24% | 0.0% |
| Q1 2018 | $1,715,000 | +12.3% | 17,507 | +6.4% | 0.24% | +11.8% |
| Q4 2017 | $1,527,000 | +16.4% | 16,453 | +7.5% | 0.21% | +8.7% |
| Q3 2017 | $1,312,000 | +1.3% | 15,300 | -0.3% | 0.20% | -11.4% |
| Q2 2017 | $1,295,000 | -2.5% | 15,347 | -1.2% | 0.22% | -7.9% |
| Q1 2017 | $1,328,000 | +10.9% | 15,536 | +1.0% | 0.24% | +2.1% |
| Q4 2016 | $1,197,000 | -2.7% | 15,377 | -2.0% | 0.23% | -6.0% |
| Q3 2016 | $1,230,000 | -18.4% | 15,693 | +5.1% | 0.25% | -25.4% |
| Q2 2016 | $1,508,000 | +59.9% | 14,931 | +50.2% | 0.33% | +50.5% |
| Q1 2016 | $943,000 | -7.4% | 9,944 | -9.3% | 0.22% | -9.0% |
| Q4 2015 | $1,018,000 | +8.1% | 10,962 | -0.9% | 0.24% | +1.2% |
| Q3 2015 | $942,000 | +7.3% | 11,058 | +7.8% | 0.24% | +14.2% |
| Q2 2015 | $878,000 | -10.0% | 10,258 | -10.8% | 0.21% | -11.3% |
| Q1 2015 | $976,000 | +18.2% | 11,499 | +19.3% | 0.24% | +14.4% |
| Q4 2014 | $826,000 | +4.8% | 9,637 | -7.1% | 0.21% | -5.5% |
| Q3 2014 | $788,000 | -3.2% | 10,374 | +0.3% | 0.22% | -4.3% |
| Q2 2014 | $814,000 | -0.2% | 10,347 | -4.8% | 0.23% | -1.7% |
| Q1 2014 | $816,000 | -8.2% | 10,874 | -5.5% | 0.23% | -7.9% |
| Q4 2013 | $889,000 | -20.6% | 11,509 | -28.7% | 0.25% | -27.2% |
| Q3 2013 | $1,119,000 | +9.0% | 16,145 | -0.5% | 0.35% | -2.5% |
| Q2 2013 | $1,027,000 | – | 16,221 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |